NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that the number of home hemodialysis (HHD) patients using its Nx2me Connected Health® platform has increased 220% in the past year.1
Nx2me® is designed to enhance the connection between NxStage® System One™ HHD patients and clinicians, and has been shown to improve patient retention and training graduation rates. Research findings demonstrate that patients using Nx2me experienced:
- 29% lower therapy discontinuation rates due to controllable causes,2 and,
- 34% reduction in technique failure, relative to match controls in patients who began using Nx2me within 3 months of initiating HHD.2
“We are really beginning to see a shift toward using innovative telehealth solutions to help improve patient outcomes with home dialysis,” said Dr. Michael Kraus, Associate Chief Medical Officer for NxStage. “Nx2me is an intuitive tool to support and proactively engage with home hemodialysis patients. The platform’s impressive performance data will continue to inform and influence home dialysis programs, ultimately helping more patients succeed on home hemodialysis.”
A key component of the Nx2me platform is the Nx2me iPad® app, which is designed to increase patients’ ease of use of home therapy by capturing treatment data and wirelessly sending it to their center after each treatment, thereby reducing the need for paper flow sheets. Dialysis center staff can access the treatment data, sent through a secured and encrypted web server, using the Nx2me Clinician Portal. The timely receipt of electronic flowsheets from the Nx2me app allows for early intervention to help reduce patient complications and hospitalizations. In addition, Nx2me integrates with center EMR systems to provide clinicians with treatment and billing information.
NxStage continues to enhance the capabilities of the Nx2me platform, introducing new features including picture sharing between patients and clinicians, and streaming video to enhance communication with NxStage Technical Support.
More information can be found here.
1. Data on file. 2018. NxStage Medical, Inc.
2. Weinhandl E, Collins AJ. Relative risk of home hemodialysis attrition in patients using a telehealth platform. Hemodial Int. 2018;22(3):318-327.